About Huber Needle
Huber needle is used in hospitals and clinics in critical care, intravascular treatments, cardiovascular surgeries, etc. These types of needles have the advantage of parter rather than cutting a plug from or coring the silicone septum of the vascular entry port or injection site. It prevents the integrity of the septum along with the silicone plug from being cut and passed into the vasculature. It provides safety and convenience during surgery or treatment. The cutting edge or the ground surface of the Huber point needle is perpendicular to the end of the needle shaft, which causes the change in the direction of the process form the heel enabling the needle to part instead of core the septum as it is inserted and withdrawn.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
CAGR | 6.7% |
To entice more end users, market players are focusing on providing Huber Needle with higher quality while adhering to all regulatory standards. In the global Huber Needle market, there are numerous large and small-scale manufacturers. They are also concentrating on the implementation of numerous advanced technologies. Furthermore, the numerous industry profits have led to the entry of new players, raising the level of rivalry in an already competitive market. The Huber Needle market is currently expanding due to the increasing number of technological advancements in medical equipment. Some of the key players in this market follow strategies, which include new product offerings, product approvals, partnerships and alliances, mergers and acquisitions, and business expansions. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
BD (BardAccess) (United States), ICU Medical Inc (Smiths Medical Inc.) (United States), Vygon SA (France), B. Braun Medical Inc. (United States), Boston Scientific Corporation (United States), Argon Medical (United States), Kawasumi Laboratories, Inc (Japan), MEDITULIP Co., Ltd. (South Korea) and Davol Inc. (United States) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Huber Needle market by Type (Safety Huber Needle {Needle-free Injection Site and Open Y-Injection Site} and Standard Huber Needle), Application (Critical Care, Obstetrics Neonatology Enteral, Intravascular Therapies, Cardiovascular & Surgery and Anesthesia & Emergency) and Region.
On the basis of geography, the market of Huber Needle has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. If we see Market by Hub, the sub-segment i.e. Winged will boost the Huber Needle market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Sales Channel, the sub-segment i.e. Hospital Pharmacies will boost the Huber Needle market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Gauge, the sub-segment i.e. 19 Gauge will boost the Huber Needle market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Availability of Huber Needles in Various Sizes According to the Applications on Port and Continuous Research and Development in Medical Devices and Instruments
Market Growth Drivers:
Growing Number of Chronic Diseases Like Cardiovascular Diseases, Cancer, and Blood-Related Diseases and Need for Managing Long Term Medication and Drug Infusion
Challenges:
High Cost Associated with Huber Needle and Risk of Infection From the Use of Huber Needle Might be the Hindrance
Restraints:
Regulatory Standards on Huber Needle and Other Medical Devices
Opportunities:
Surging Investment in Healthcare Infrastructure and Services will Boost the Huber Needle Market and Advantage of Safety and Convenience in Treatment Associated with Huber Needle
Market Leaders and their expansionary development strategies
January 6, 2022, ICU Medical Inc. announced that it has completed its acquisition of Smiths Medical from Smiths Group plc. The Smiths Medical business includes a syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical’s existing businesses, the combined companies create a leading infusion therapy company with estimated pro forma combined revenues of approximately USD 2.5 billion.
In July 2022, B. Braun Medical Inc. (B. Braun), a leader in infusion therapy, announced today the launch of its new Introcan Safety 2 IV Catheter with one-time blood control. The Introcan Safety 2 IV Catheter is the latest development from B. Braun for making IV access safer for the clinician by reducing the risk of needlestick injuries and their exposure to blood.
"According to the World Health Organisation (WHO) document, some devices should never be re-used. For example, single-use injection syringes because the risk of infection is very high. Field data from developing countries revealed that the re-use of injection syringes/needles is a major source of HIV and hepatitis infections. In the United States, FDA subjects the reprocessor of a single-use device to the same regulatory requirements as those for the original manufacturer of the device."
Key Target Audience
Huber Needle Manufacturers, Huber Needle International Traders, Huber Needle Distributors and Suppliers, Research and Development Institutes, Potential Investors, Regulatory Bodies, Hospitals and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.